Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If You Knew What He Is Saying, Then You Would Know What's Coming !!!
GIDDY-UP !!!
https://podcasts.apple.com/podcast/id1217141650?i=1000576209810
The Market Is.... ALWAYS CLULESS.... UNTIL THE PRESS RELEASE !!!
Zelensky: Europe 'one step away from a radiation disaster'
https://www.msn.com/en-us/news/world/zelensky-europe-one-step-away-from-a-radiation-disaster/ar-AA117vx4
Big Drop In Short Interest !!!
08/15/2022 201,490---- 201,490 Shares Short
07/29/2022 353,375-----353,375 Shares Short
https://www.nasdaq.com/market-activity/stocks/plur/short-interest
PLURI...May Have The Cure For... ALL HUMAN ADDICTIONS ???
https://legacy.pluristem.com/wp-content/uploads/2022/07/pharmaceutics-14-01311-v2.pdf
New Tute
2022-08-19 BRSIX - Ultra-Small Company Market Fund 112,600 PLUR SHARES
https://fintel.io/so/us/psti
Shutting Down Ukraine Nuclear Power Plant Could Have Worldwide Consequences
https://www.msn.com/en-us/news/world/shutting-down-ukraine-nuclear-power-plant-could-have-worldwide-consequences/ar-AA10NCsr
Zelensky warns of ‘catastrophic consequences’ from Russian actions at nuclear plant
https://news.yahoo.com/zelensky-warns-catastrophic-consequences-russian-175134958.html
Ukraine fears Russian false-flag attack at nuclear power plant: report
https://nypost.com/2022/08/18/ukraine-fears-false-flag-attack-at-nuclear-plant-report/
Ukraine: Russia tells nuclear plant employees not to work on Friday
Ukraine's military intelligence service is warning of a possible Russian operation at the Zaporizhzhya nuclear power plant on Friday after workers there were told to stay home.
The plant's Russian occupiers unexpectedly announced a work-free day on Friday at Europe's largest nuclear power plant, the Defence Ministry's intelligence service posted on Facebook.
Only the operating crew was to remain at the site while everyone else will be banned from entering, it said.
It was feared that Russian forces were now "upping the ante" and planning to commit a terrorist attack following their shelling of the nuclear plant, the statement said. Details were not provided and Russia has yet to comment.
https://www.msn.com/en-xl/news/other/ukraine-russia-tells-nuclear-plant-employees-not-to-work-on-friday/ar-AA10Oh93
That's Top Secret.... Classified Information.
Ukraine on brink of ‘terrifying radiation fallout’ in Chernobyl-like nuclear accident
https://www.express.co.uk/news/world/1657192/russia-ukraine-war-news-zaporizhzhia-nuclear-accident-chernobyl-vn
PLX-R18 RESTORES ALL 3 BLOOD COMPONENTS !!! WHITE/RED/PLATELETS !!! ONLY DRUG IN THE WORLD THAT CAN DO THAT !!! THEONLY ONE !!!
Scientists simulate spread of radiation in case of accident at Zaporizhzhia Nuclear Power Plant
https://news.yahoo.com/scientists-simulate-spread-radiation-case-095357590.html
FDA Approves PLX-R18 Cell Therapy for Emergency Use for Acute Radiation Syndrome.
https://www.docwirenews.com/hematology-oncology/fda-approves-plx-r18-cell-therapy-for-emergency-use-for-acute-radiation-syndrome/
Russia warns nuclear plant disaster will spill radiation over three European countries
https://www.mirror.co.uk/news/world-news/russia-warns-nuclear-plant-disaster-27772885
Next Week !!!
The Clock Started Ticking On February 24, 2022 !!!
The First Warrant issued to Tnuva permits Tnuva to purchase up to 125,000 ordinary shares of Plurinuva at an exercise price of $40.00 per share, and has a term commencing on the Closing Date and ending at the earlier of (i) six months from the Closing Date, (ii) immediately prior to and subject to the consummation of an initial public offering or acquisition of Plurinuva or (iii) the consummation of a financing round with a non-affiliated investor. In addition, on the six months anniversary of the Closing Date, and provided that the First Warrant has not expired, Plurinuva shall issue to Tnuva the Second Warrant, which will permit Tnuva to purchase up to a number of ordinary shares of Plurinuva, or the then most senior securities issued by Plurinuva, in consideration for such amount equal to 200% of the remaining balance of the aggregate purchase price of the First Warrant, provided that Tnuva exercises at least 62,500 ordinary shares at a price per share of $40.00, or $2,500 in the aggregate, of the First Warrant. The Second Warrant’s exercise price per share equals $76.00. The Second Warrant has a term commencing on the six months anniversary of the Closing Date and ending at the earlier of (i) six months from its issuance, (ii) immediately prior to and subject to the consummation of an initial public offering or acquisition of Plurinuva or (iii) the consummation of a financing round with a non-affiliated investor.
The Company allocated the consideration received in the total amount of $7,500 between the ordinary shares and the warrants of Plurinuva issued to Tnuva such that the consideration allocated to the ordinary shares is $6,718 and consideration allocated to the warrants is $782.
More Tutes Buying
MILLENNIUM MANAGEMENT LLC 140,715 PLUR SHARES
https://fintel.io/so/us/psti
More Tute Buying
8/15-SUSQUEHANNA INTERNATIONAL GROUP, 123,441 PLUR SHARES
8/15-BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,600 PLUR SHARES
8/15-RENAISSANCE TECHNOLOGIES LLC ADDED TO THEIR CURRENT PLUR HOLDINGS WITH A BUY OF 31,600 PLUR SHARES
https://whalewisdom.com/stock/psti
Pluri: where technology comes to life
FYI: The TASE Is Closed Sunday August 7th
Video....Pioneering Israeli Biotech: Pluri CEO Yaky Yanay
Stem Cell Therapy Market Size to Surpass USD 31.41 Bn by 2030
https://uk.finance.yahoo.com/news/stem-cell-therapy-market-size-142600985.html
PAGE 26
GENETICALLY MODIFIED CELLS
? Collaboration with CRISPR-IL consortium developing
genetically edited PLX cells tailored for treatment of
indications with unmet needs
https://legacy.pluristem.com/wp-content/uploads/2021/06/Pluri-company-pp_Q3-2022.pdf
Radiation Injury Treatment Network’s 2022 Workshop
Past Informing the Present, Past Improving the Plan for a Rad/Nuc Incident
Pluri VP Data and IP Dr. Racheli Ofir will speak about placenta-derived PLX-R18 stromal cells for emergency treatment and prevention of H-ARS on August 4-5, 2022 in Alexandria, VA
We are thrilled to share a new part of our journey: our recent official name change from Pluristem to Pluri.
https://legacy.pluristem.com/pluristem-blog/pluri-where-technology-comes-to-life/
New Tute
08-01-2022 13F Meitav Dash Investments Ltd 167,593 Shares
https://fintel.io/so/us/psti
AND WE’RE JUST GETTING STARTED !!!
Pluri will seek collaborations and strategic alliances with industries that require cells and cell-extract development and manufacturing. We will develop strategic partners who understand market demands and have access to a strong customer base. Our commercialization strategy will consist of licensing and joint ventures that we like to call “Pluri focus units”. We expect that these will have separate funding and seasoned management but will benefit from full access to our platform. I am proud to share the vision of Pluri: to help pioneer a biotech revolution to create a range of next-generation cell-based products that improve human wellbeing, increase sustainability, and advance solutions to humanity’s greatest challenges.
The new name reflects the Company’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cell-based products that address various life challenges, while also promoting global wellbeing and sustainability.
Pluri’s technology will continue to fuel medical research and develop pharmaceuticals, while also being used to potentially create novel cell-based solutions for other innovative initiatives—such as food-tech, agri-tech, and biologics—either independently or through partnerships, to drive global wellbeing and sustainability.
“We believe that there is tremendous need in many industries for a cell-based development platform that provides quality and precision yet is also efficient, scalable, cost effective, and consistent batch to batch. Pluri’s technology offers all these capabilities and more,” said Pluri’s CEO and President Yaky Yanay. “After nearly two decades as Pluristem, we are proud to expand as Pluri, leveraging our revolutionary technology to increase our market share across multiple verticals. Like our new logo’s dot-connecting arch suggests, it is time for Pluri to move from this single point to next generation products across a range of fields.”
Pluri’s first collaboration, based on its innovative 3D cell-based technology platform, was formed in January 2022 to produce sustainable cultured food with Israeli food giant Tnuva Group.
The Company intends to continue bringing technology to life, creating next-generation cell-based products that improve human wellbeing, increase environmental sustainability, and advance solutions to the challenges of the future.
“Our goal is to transform cells into solutions that make the world a better place,” said Yanay. “Increasing our activity across multiple verticals means we can do even more to improve human life and contribute to a more sustainable planet. We look to solve our globe’s largest and most pressing issues starting with the smallest unit of any organism: a single cell.”
After Meat and Seafood—Coffee could be the next thing grown in a lab
https://www.futurimmediat.net/news/cell-cultured-coffee
https://www.foodnavigator.com/Article/2022/07/13/Stem-Cell-cultured-coffee-start-up-targets-specialty-arabica-market
Pluri-Coffee Coming ???
Global Coffee Market was valued at USD 465.9 billion in the year 2020
“We chose to collaborate with Pluri (formerly Pluristem) because we believe it owns one of the most advanced cell production technologies in the world. We expect the collaboration between the companies to revolutionize the cultured food industry and develop the next generation of alternative proteins." Eyal Malis, CEO Tnuva Group
Most People Like To Buy A Stock At A Higher Price !!! They Are Completely Clueless About What's Coming !!!
Scotty....Never Did Have A Clue...Quite Sad.
FYI:
It's Quite Possibly....In The Video, At Exactly The 1 Minute Mark, There Is A Brief Glimpse Of A Possible Pluri-Steak On A White Plate ???
Page 26
Pipeline of additional targeted products in development using
genetic engineering approaches
GENETICALLY MODIFIED CELLS
? Collaboration with CRISPR-IL consortium developing
genetically edited PLX cells tailored for treatment of
indications with unmet needs
https://legacy.pluristem.com/wp-content/uploads/2021/06/Pluri-company-pp_Q3-2022.pdf